326 related articles for article (PubMed ID: 10736998)
1. [Hemorrhoids and conservative treatment. Review of the literature on the use of diosmin and micronized hesperidin].
La Torre F; Nicolai AP; Otti M
Minerva Chir; 1999 Dec; 54(12):909-16. PubMed ID: 10736998
[No Abstract] [Full Text] [Related]
2. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
Amato C
Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids.
Cospite M
Angiology; 1994 Jun; 45(6 Pt 2):566-73. PubMed ID: 8203789
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].
Hnátek L
Vnitr Lek; 2015 Sep; 61(9):807-14. PubMed ID: 26465280
[TBL] [Abstract][Full Text] [Related]
5. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form.
Cospite M; Dominici A
Int Angiol; 1989; 8(4 Suppl):61-5. PubMed ID: 2698903
[TBL] [Abstract][Full Text] [Related]
6. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study.
Corsale I; Carrieri P; Martellucci J; Piccolomini A; Verre L; Rigutini M; Panicucci S
Int J Colorectal Dis; 2018 Nov; 33(11):1595-1600. PubMed ID: 29934701
[TBL] [Abstract][Full Text] [Related]
7. [Results of the use of topical diosmin (venosmine) in the treatment of acute hemorrhoid pathology].
Tajana A; Boccasanta P; Micheletto G; Orio A
Minerva Med; 1988 May; 79(5):387-90. PubMed ID: 3287228
[TBL] [Abstract][Full Text] [Related]
8. Daflon 500 mg in the treatment of hemorrhoidal disease: a demonstrated efficacy in comparison with placebo.
Godeberge P
Angiology; 1994 Jun; 45(6 Pt 2):574-8. PubMed ID: 8203790
[TBL] [Abstract][Full Text] [Related]
9. [Conservative and surgical measures in phlebologic consulatation. Report on the potassium-neutral venous diuretic Dehydro-sanol-tri].
Wissniowski T; Harlin-Wissniowski A
Fortschr Med; 1974 Oct; 92(28):1132-7. PubMed ID: 4616896
[No Abstract] [Full Text] [Related]
10. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
Geroulakos G; Nicolaides AN
Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of a highly standardized and bioavailable mixture of flavonoids and triterpenes in the management of acute hemorroidal crisis.
Di Pierro F; Spinelli G; Monsù G; Alvisi G; Bacci G; Baiocchi C; Buratta M; Martinoli A; Vitali F; Agrifoglio C; Gennaioli F; Lucarelli M
Acta Biomed; 2011 Apr; 82(1):35-40. PubMed ID: 22069954
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility.
Galley P; Thiollet M
Int Angiol; 1993 Mar; 12(1):69-72. PubMed ID: 8376915
[TBL] [Abstract][Full Text] [Related]
13. Effect of Pycnogenol on the Healing of Venous Ulcers.
Toledo RR; Santos MERC; Schnaider TB
Ann Vasc Surg; 2017 Jan; 38():212-219. PubMed ID: 27521821
[TBL] [Abstract][Full Text] [Related]
14. The role of Daflon in the treatment of acute hemorrhoids.
Panijayanond P; Chotiprasidhi P
J Med Assoc Thai; 1985 Feb; 68(2):72-80. PubMed ID: 4009089
[No Abstract] [Full Text] [Related]
15. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients.
Guilhou JJ; Dereure O; Marzin L; Ouvry P; Zuccarelli F; Debure C; Van Landuyt H; Gillet-Terver MN; Guillot B; Levesque H; Mignot J; Pillion G; Février B; Dubeaux D
Angiology; 1997 Jan; 48(1):77-85. PubMed ID: 8995348
[TBL] [Abstract][Full Text] [Related]
16. At the Crossroads of Venous Insufficiency and Hemorrhoidal Disease: Daflon 500 mg. Proceedings of a symposium. Vienna, Austria, January 31, 1992.
Angiology; 1994 Jun; 45(6 Pt 2):493-584. PubMed ID: 7911285
[No Abstract] [Full Text] [Related]
17. Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids: randomized controlled trial.
Ho YH; Tan M; Seow-Choen F
Dis Colon Rectum; 2000 Jan; 43(1):66-9. PubMed ID: 10813126
[TBL] [Abstract][Full Text] [Related]
18. Flavonoids to reduce bleeding and pain after stapled hemorrhoidopexy: a randomized controlled trial.
Mlakar B; Kosorok P
Wien Klin Wochenschr; 2005 Aug; 117(15-16):558-60. PubMed ID: 16158207
[TBL] [Abstract][Full Text] [Related]
19. Micronized flavonoid therapy in internal hemorrhoids of pregnancy.
Buckshee K; Takkar D; Aggarwal N
Int J Gynaecol Obstet; 1997 May; 57(2):145-51. PubMed ID: 9184951
[TBL] [Abstract][Full Text] [Related]
20. [Results of a field study with dehydro sanol tri from a statistical point of view].
Haase W
Med Welt; 1978 Jan; 29(4):150-6. PubMed ID: 345041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
